BioPlus Acquisition Corp. (BIOS)
NASDAQ: BIOS
· Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM
BioPlus Acquisition Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.45K | 35.37K | 140.3K | 107.07K | 294.69K | 442.72K | 635.54K | 936.00 | 23.69 | 25K |
Short-Term Investments | 138.43M | 240.37M | 237.78M | 235.88M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 237.78M | 235.88M | 234.93M | 234.65M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 138.43M | 240.37M | n/a | n/a | 156.46K | 308.47K | 234.98M | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 194.38K | 411.77K | 408.46K | 521.48K | 420.85K | 374.42K | 366.74K | 3.44K | 0.14 | n/a |
Total Current Assets | 196.84K | 447.14K | 548.76K | 628.56K | 715.54K | 817.14K | 1M | 4.38K | 23.83 | 25K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 138.43M | 240.37M | 237.78M | 235.88M | 235.09M | 234.96M | 234.98M | 501.58K | n/a | 164.86K |
Total Assets | 138.63M | 240.82M | 238.32M | 236.51M | 235.81M | 235.78M | 235.98M | 505.96K | n/a | 189.86K |
Account Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | 408.46K | 521.48K | 420.85K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 250K | n/a | n/a | n/a | n/a | n/a | n/a | 130K | n/a | n/a |
Other Current Liabilities | 1.73M | 700.53K | 526.88K | 288.45K | 241.53K | 239.72K | 179.14K | 357.98K | 505.73 | 169.86K |
Total Current Liabilities | 1.98M | 700.53K | 526.88K | 288.45K | 241.53K | 239.72K | 179.14K | 487.98K | 505.73 | 169.86K |
Long-Term Debt | 5M | 5M | 5M | 5M | 5M | 5M | 5M | n/a | n/a | n/a |
Other Long-Term Liabilities | 9.8M | 9.8M | 9.8M | 9.8M | 9.8M | 9.8M | 9.8M | n/a | n/a | n/a |
Total Long-Term Liabilities | 14.8M | 14.8M | 14.8M | 14.8M | 14.8M | 14.8M | 14.8M | n/a | n/a | n/a |
Total Liabilities | 16.78M | 15.5M | 15.33M | 15.09M | 15.04M | 15.04M | 14.98M | 487.98K | 505.73 | 169.86K |
Total Debt | 5.25M | 5M | 5M | 5M | 5M | 5M | 5M | 130K | n/a | n/a |
Common Stock | 138.43M | 240.37M | 237.78M | 235.88M | 234.94M | 234.6M | 234.6M | 575.00 | 0.52 | 575.00 |
Retained Earnings | -16.58M | -15.05M | -14.78M | -14.46M | -14.17M | -13.86M | -13.6M | -7.02K | -6.14 | -5K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 121.85M | 225.32M | 223M | 221.42M | 220.76M | 220.74M | 221M | 17.98K | 18.86 | 20K |
Total Investments | 138.43M | 240.37M | 237.78M | 235.88M | 234.93M | 234.65M | n/a | n/a | n/a | n/a |